Allarity Therapeutics, Inc. Shareholders' Equity
Allarity Therapeutics, Inc. (ALLR) had Shareholders' Equity of $3.54 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $3.54M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.92M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $12.01M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $3.54M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.92M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $9.83M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $12.01M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $12.17M 10-Q · filed 2026-08-14 | $12.17M 10-Q · filed 2025-08-15 |
| 2025-03-31 | $18.67M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $11.81M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $12.96M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $19.84M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$6.47M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$2.75M 10-K · filed 2026-03-30 | |
| 2023-09-30 | -$3.38M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$723.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$3.10M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$113.00K 10-K · filed 2025-03-31 | |
| 2022-09-30 | $1.45M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $7.97M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $14.73M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $18.15M 10-K · filed 2024-03-08 | |
| 2021-09-30 | $29.66M 10-Q · filed 2022-11-14 | $32.77M 10-Q · filed 2021-11-23 |
| 2021-06-30 | $28.82M 10-Q · filed 2022-11-14 | $28.82M 10-Q · filed 2021-11-23 |
| 2021-03-31 | $23.47M 10-Q · filed 2022-11-14 | $25.92M 10-Q · filed 2021-11-23 |
| 2020-12-31 | $24.44M 10-K · filed 2023-03-13 | $26.85M 10-Q · filed 2021-11-23 |
| 2020-09-30 | $22.74M 10-Q/A · filed 2022-05-17 | $24.66M 10-Q · filed 2021-11-23 |
| 2020-06-30 | $21.36M 10-Q/A · filed 2022-05-17 | $22.75M 10-Q · filed 2021-11-23 |
| 2020-03-31 | $21.01M 10-Q/A · filed 2022-05-17 | $22.29M 10-Q · filed 2021-11-23 |
| 2019-12-31 | $20.04M 10-Q/A · filed 2022-05-17 | $20.90M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |